Roflumilast Suppliers and Product Information

**Synonyms:** ROFLUMILAST, 3-Cyclopropylmethoxy-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide, B-9302-107, BY-217, BYK-20869, Daxas

**Chemical Properties:** - Melting point: 158°C - Boiling point: 430.6±45.0°C - Predicted density: 1.471±0.06 g/cm³ - Predicted storage temp: -20°C

**Product Categories:** Roflumilast, Daxas, Inhibitors, Intermediates, Fine Chemicals, APIs, API, All Inhibitors, Pharmaceuticals

Frequently Asked Questions about Roflumilast

**Q: What is Roflumilast used for?** A: Roflumilast is primarily used as a treatment for chronic obstructive pulmonary disease (COPD). It helps reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.

**Q: How does Roflumilast work?** A: Roflumilast is a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE4). By inhibiting PDE4, it helps reduce inflammation in the lungs, which is a key factor in COPD.

**Q: What is the typical dosage form of Roflumilast?** A: Roflumilast is typically available as an oral tablet, usually taken once daily.

**Q: Are there any common side effects of Roflumilast?** A: Common side effects may include diarrhea, weight loss, nausea, headache, back pain, flu-like symptoms, insomnia, and dizziness. It's important to consult with a healthcare provider for a complete list of potential side effects.

**Q: Is Roflumilast available as a generic medication?** A: Yes, generic versions of Roflumilast are available in some markets, in addition to the brand name version Daxas.